MARKSANS PHARMA
|
MARKSANS PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹504 Cr | ₹424 Cr | ₹338 Cr | ₹248 Cr | ₹302 Cr |
| Adjustment | ₹69 Cr | ₹55 Cr | ₹74 Cr | ₹35 Cr | ₹57 Cr |
| Changes In working Capital | ₹-241 Cr | ₹-126 Cr | ₹-111 Cr | ₹-111 Cr | ₹-132 Cr |
| Cash Flow after changes in Working Capital | ₹333 Cr | ₹353 Cr | ₹300 Cr | ₹172 Cr | ₹227 Cr |
| Cash Flow from Operating Activities | ₹207 Cr | ₹230 Cr | ₹237 Cr | ₹99 Cr | ₹179 Cr |
| Cash Flow from Investing Activities | ₹-49 Cr | ₹-141 Cr | ₹-259 Cr | ₹-84 Cr | ₹-45 Cr |
| Cash Flow from Financing Activities | ₹-65 Cr | ₹-69 Cr | ₹198 Cr | ₹80 Cr | ₹-15 Cr |
| Net Cash Inflow / Outflow | ₹93 Cr | ₹21 Cr | ₹176 Cr | ₹94 Cr | ₹118 Cr |
| Opening Cash & Cash Equivalents | ₹403 Cr | ₹382 Cr | ₹206 Cr | ₹112 Cr | ₹94 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | ₹0.00 Cr | - | - |
| Closing Cash & Cash Equivalent | ₹496 Cr | ₹403 Cr | ₹382 Cr | ₹206 Cr | ₹212 Cr |
Compare Cashflow Statement of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹11,545.3 Cr | 2% | 17.1% | -6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 2% |
17.1% |
-6.2% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses